Epitranscriptomics in atherosclerosis: Unraveling RNA modifications, editing and splicing and their implications in vascular disease

Vascular Pharmacology

DOI: 10.1016/j.vph.2025.107496 Full text (OA) OpenAlex

Authors 0

Author list not loaded yet.

Cited by 1 stored of 13

Editorial: Multiomic approaches in atherosclerosis
2025 Vascular Pharmacology editorial Immunology and Microbiology Atherosclerosis and Cardiovascular Diseases Open access

0

citations

1 result

References 6

Adenosine-to-Inosine Editing of Vasoactive MicroRNAs Alters Their Targetome and Function in Ischemia
2020 Molecular Therapy — Nucleic Acids article Biochemistry, Genetics and Molecular Biology RNA regulation and disease Open access

44

citations
C/D box snoRNA SNORD113-6/AF357425 plays a dual role in integrin signalling and arterial fibroblast function via pre-mRNA processing and 2′O-ribose methylation
2021 Human Molecular Genetics article Biochemistry, Genetics and Molecular Biology RNA Research and Splicing Open access

27

citations
The epitranscriptome: RNA modifications in vascular remodelling
2022 Atherosclerosis article Biochemistry, Genetics and Molecular Biology RNA modifications and cancer Open access

23

citations
Recommendations for detection, validation, and evaluation of RNA editing events in cardiovascular and neurological/neurodegenerative diseases
2023 Molecular Therapy — Nucleic Acids article Biochemistry, Genetics and Molecular Biology RNA regulation and disease Open access

21

citations
Filamin A pre-mRNA editing modulates vascularization and tumor growth
2022 Molecular Therapy — Nucleic Acids article Biochemistry, Genetics and Molecular Biology RNA regulation and disease Open access

14

citations
Site‐specific m6A‐miR‐494‐3p, not unmethylated miR‐494‐3p, compromises blood brain barrier by targeting tight junction protein 1 in intracranial atherosclerosis
2024 British Journal of Pharmacology article Neuroscience Barrier Structure and Function Studies Open access

7

citations

6 results